A DNA dual lock-and-key strategy for cell-subtype-specific siRNA delivery by Ren, K et al.
ARTICLE
Received 29 Jan 2016 | Accepted 17 Oct 2016 | Published 24 Nov 2016
A DNA dual lock-and-key strategy
for cell-subtype-speciﬁc siRNA delivery
Kewei Ren1,*, Ying Liu1,*, Jie Wu1, Yue Zhang1, Jing Zhu1, Min Yang2 & Huangxian Ju1
The efﬁcient and precise delivery of siRNA to target cells is critical to successful gene therapy.
While novel nanomaterials enhance delivery efﬁciency, it still remains challenging for precise
gene delivery to overcome nonspeciﬁc adsorption and off-target effect. Here we design a dual
lock-and-key system to perform cell-subtype-speciﬁc recognition and siRNA delivery. The
siRNA is self-assembled in an oligonucleotide nano vehicle that is modiﬁed with a hairpin
structure to act as both the ‘smart key’ and the delivery carrier. The auto-cleavable hairpin
structure can be activated on site at target cell membrane by reacting with two aptamers as
‘dual locks’ sequentially, which leads to cell-subtype discrimination and precise siRNA
delivery for high efﬁcient gene silencing. The success of this strategy demonstrates the
precise delivery of siRNA to speciﬁc target cells by controlling multiple parameters, thus
paving the way for application of RNAi in accurate diagnosis and intervention.
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G
ene interference technology that selectively silences gene
expression and inhibits protein transcription by delivering
small interference RNA (siRNA) in mammalian cells is
becoming a promising approach for the precise treatment of
human diseases, including cancer and metabolic, neurodegenera-
tive and infectious diseases1,2. One of the key challenges to realize
the broad clinical application of RNA interference (RNAi)
therapy is its delivery speciﬁcity3–5. A cell-speciﬁc and efﬁcient
delivery system is highly desired to improve selective cellular
uptake, decrease the overall dosage of siRNAs and avoid
nonspeciﬁc adsorption as well as minimize off-target silencing
in non-target cells6. A number of ligands that selectively bind
tissue-associated antigens have been explored for targeted siRNA
delivery, including antibody–protamine fusion proteins7,8 and
aptamer-siRNA chimeras9,10. However, most receptors are often
shared by multiple types of cell, or a receptor overexpressed in
diseased cells is also expressed at a low level in normal cells,
therefore the single-receptor-targeted delivery system potentially
results in off-target toxicities and serious complications11. Since
cells express multiple surface receptors, simultaneously assessing
multiple surface receptors to recognize speciﬁc disease cells and
enhance diagnostic and therapic accuracy in similar cells should
be a more practical and less risk approach12. Taking advantages
of autonomous DNA strand displacement cascades reaction13,
programmable dual parameters controlled DNA logic platform
has been used for cancer cell recognition14 and photodynamic
therapy15,16. However, the DNA logic platform has not been used
for siRNA delivery due to the limitation of using toehold-
mediated strand displacement cascade reaction as an efﬁcient
delivery carrier. The precise delivery of siRNA to speciﬁc target
cells is still an urgent need.
A variety of materials have been explored as siRNA delivery
carriers, such as liposomes, cationic polyelectrolytes and inor-
ganic nanoparticle17–19. However, these conventional delivery
vehicles suffer from low loading efﬁciency, less cell-speciﬁc
manner, complex surface modiﬁcation process and/or the damage
of immunogenic response or toxicity20,21. Self-assembled DNA
nanostructures can offer the advantages of ﬂexible design,
controllable size and orientation, ease of bioconjugation and
excellent biocompatibility, and have demonstrated potential
application in biosensing and drug delivery22–24. Here a
self-assembled oligonucleotide nano vehicle (ONV) and a ‘dual
lock-and-key’’ were designed to load siRNA for controllable
siRNA delivery. The ONV structure conferred higher payload
capacity, which signiﬁcantly increased cell uptake. Besides,
different cell-recognition aptamers could be conveniently
incorporated into ONV via hybridization, and the rigid
tube-like structure improved resistance to nuclease degradation
upon endocytosis25,26.
The incorporation of two factors in a delivery system to
function in a serial manner can improve the site-speciﬁc
transport and lower the non-target cytotoxicity27. Here an
auto-cleavable hairpin structure is used to modify the siRNA-
loaded ONV (siRNA-ONV) and act as the ‘smart key’, and two
kinds of aptamers, sgc8c and sgc4f16, are bound on cell surface to
act as the ‘double locks’. The ‘locks’ can be opened sequentially by
reacting with the ‘key’ in a serial manner. The speciﬁc double
recognition mode controls the cell ‘locked-open’ status, and thus
achieves cell-subtype-speciﬁc recognition and precise siRNA
delivery. Upon reaction with Zn2þ -dependent MNAzyme on
sgc4f, the hairpin structure oligonucleotide in siRNA-ONV is
auto-cleaved to form single strand, which activates the ‘smart key’
on site at cell membrane. The ‘locked’ hairpin structure of sgc8c is
thus opened by hybridizing with the cleaved single-strand
oligonucleotide in siRNA-ONV subsequently to mediate the
precise delivery of siRNA into speciﬁc target cells. To the best of
our knowledge, this is the ﬁrst try of precise siRNA delivery and
gene silencing with the participation of multiple cell membrane
receptors. Previously reported siRNA delivery methods all rely on
only one receptor on cell surface7–10, therefore usually suffer from
the high nonspeciﬁc interaction and off-target toxicity to other
cells. In comparison with ‘single-parameter’-controlled siRNA
delivery, the ‘dual lock-and-key’-controlled siRNA delivery
system activates two recognition elements on site at target cell
membrane just before the delivery process, therefore affords
substantial improvement for delivery speciﬁcity and avoids off-
target toxicities, which is of great importance to the application of
RNAi in precise diagnosis and treatment.
Results
Preparation siRNA-ONV. The triangular rung units (TRUs)
with two overhangs at each end were synthesized ﬁrst as building
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Figure 1 | Schematic illustration of ‘dual lock-and-key’-controlled cell-subtype-speciﬁc siRNA delivery. (a) Self-assembly synthesis of siRNA-TRU
repeating unit, (b) self-assembly synthesis of siRNA-ONV nanotube and (c) siRNA delivery principle.
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blocks for ONV (Fig. 1a)28. siRNAs were hybridized with the
overhangs of TRU, and the synthesis of siRNA-TRU was
conﬁrmed by 8% polyacrylamide gel electrophoresis (PAGE)
experiment (Fig. 2a). Upon mixing seven oligonucleotides of C1,
C2, V1, R1, R2, antisense siRNA and siRNA strands, a distinct
bright band that migrated much slower than all components was
observed (lane 8, Fig. 2a), indicating the successful synthesis of
siRNA-TRU. The siRNA-TRUs were subsequently assembled
with a long continuous DNA backbone strand produced by
rolling circle ampliﬁcation (RCA) to form siRNA-ONV (Fig. 1b).
The synthesis process of siRNA-ONV was characterized in
Fig. 2b, it showed a lower-mobility band appeared in lane 3 after
the RCA reaction, suggesting the formation of DNA backbone.
When DNA backbone was mixed with the siRNA-TRU (lane 4,
Fig. 2b), the band for siRNA-TRU disappeared and a
strengthened band was obtained in the sample loading zone,
showing the successful preparation of siRNA-ONV (Fig. 2b,
lane 5). The siRNA-ONV structure was also characterized by
atomic force microscopy (AFM). The siRNA-ONV tubes
appeared to be quite rigid and well dispersed with an average
length of 0.60±0.15 mm (Fig. 2c) (± indicates the length range
of siRNA-ONV tubes according to 10 times replicate
measurements), which consists with the previously reported
self-assembly DNA nanotube structure28,29. Given that the
siRNA-TRU is 14.3 nm in length30, 42±10 siRNA-TRU
repeating units were counted for each siRNA-ONV, indicating
the loading capacity of 84±20 siRNA for siRNA-ONV.
To verify the serum stability of siRNA-ONV, Cy3-tagged
siRNA and black hole quencher 2 (BHQ2)-tagged R1 and R2
oligonucleotides were used as components to assemble self-
quenched siRNA-ONV (SQ-siRNA-ONV). The ﬂuorescence
recovery of Cy3-siRNA from SQ-siRNA-ONV disassembly was
measured in 10% fetal bovine serum (FBS) reaction buffer over
12 h (Supplementary Fig. 1a). Compared with the control couple
of self-quenched double-strand siRNA (SQ-ds-siRNA), the
ﬂuorescence recovery from SQ-siRNA-ONV was much less,
demonstrating that ONV nanotube structure could protect
siRNA from nuclease degradation. The melting temperature
(Tm) of siRNA-ONV was 72.1 C (Supplementary Fig. 1b,c),
demonstrating good thermal stability.
Mechanism of double locks controlled siRNA delivery.
The feasibility of dual parameter sequentially controlled ‘lock-
and-key’ system was veriﬁed with PAGE analysis by mixing the
hairpin structure oligonucleotide (DNA primer) in ONV with the
‘locks’ (sgc8c and sgc4f aptamers) together and respectively
(Supplementary Fig. 2a). Although sgc8c aptamer and DNA
primer had the complementary sequences, their individual
‘closed’ hairpin structure prevented the hybridization, demon-
strated by two separate bands for the mixture solution
(Supplementary Fig. 2a, lanes 4). The hairpin structure
DNA primer had an auto-cleavable position, which could be
autocatalytically cleaved by the Zn2þ -dependent MNAzyme
containing sgc4f aptamer to form DNA single strand. The cleaved
single-strand DNA primer hybridized with sgc8c aptamer to open
its hairpin structure, acting as a smart key to be activated on site
by reacting sequentially with double locks sgc4f and sgc8c. Upon
the addition of sgc4f aptamer in the mixture of sgc8c and DNA
primer, the bands representing sgc8c and DNA primer dis-
appeared, and a new band with much lower mobility appeared
(Supplementary Fig. 2a, lanes 5), indicating the hybridization of
single-strand DNA primer with sgc8c. The feasibility of the ‘dual
lock-and-key’-controlled system was further conﬁrmed by
observing ﬂuorescence recovery from self-quenched aptamer
BHQ2-sgc8c. The hairpin structure aptamer sgc8c was labelled
with Cy3 and BHQ2 on each stem terminus. The ‘locked’ sgc8c
aptamer kept hairpin structure in the absence of sgc4f aptamer
or/and ‘smart key’ ONV, thus only very weak ﬂuorescence was
observed. In the presence of both sgc4f and ONV, the mixture
solution demonstrated strong ﬂuorescent intensity due to the
opening of hairpin structure sgc8c aptamer and corresponding
Cy3 ﬂuorescence recovery (Supplementary Fig. 2b).
Sgc8c and sgc4f aptamers are bound to their individual
receptors expressed by different cells. Sgc8c binds to cell
membrane receptor tyrosine protein kinase-7, while the cell
membrane receptor for sgc4f is not yet identiﬁed16. After
different cells were incubated with ﬂuorescein dye (FAM)
labelled aptamers, strong FAM ﬂuorescence were observed from
their corresponding target cells in ﬂow cytometric assay
(Supplementary Fig. 3), which indicated human cervix
carcinoma (HeLa) cells only bound sgc8c aptamer, and human
Burkitt’s lymphoma (Ramos) cells only bound sgc4f aptamer,
while both sgc8c and sgc4f aptamers were bound to human acute
lymphoblastic leukaemia (CEM) cells, indicating the binding
selectivity of sgc8c and sgc4f to their respective target cells.
The ‘double locks’ controlled CEM cell-subtype-speciﬁc
siRNA-ONV delivery was relied on the sequential opening of
locks sgc8c and sgc4f (Fig. 1c). The ﬂuorescence from
Cy3-labelled siRNA-ONV (Cy3-siRNA-ONV) was only observed
within CEM cells in the presence of both sgc8c and sgc4f
aptamers, while no ﬂuorescence was observed in the absence of
either aptamer (Supplementary Fig. 4a). This result was also
conﬁrmed by ﬂow cytometric assay (Supplementary Fig. 4b).
Z-stack images of CEM cells were used to verify the internaliza-
tion of Cy3-siRNA-ONV in CEM cells31. The ﬂuorescence signals
from Cy3 and the nucleus staining were located at the same
focal plane and exhibited a position-sensitive dependence,
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Figure 2 | Characterization of siRNA-ONV self-assembly. (a) PAGE analysis of siRNA-TRU self-assembly. Lanes 1–9 represent C1, C2, V1, R1, R2,
antisense siRNA, siRNA, the mixture of lines 1–7 and DNA ladder marker. (b) PAGE analysis of siRNA-ONVself-assembly. Lanes 1–6 represent DNA primer,
circular DNA template, DNA backbone, siRNA-TRU, siRNA-ONV and DNA ladder marker. (c) AFM image of siRNA-ONV. Phase image: scale bar, 300 nm.
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demonstrating intracellular localization of Cy3-siRNA-ONV
(Supplementary Fig. 4c).
Speciﬁcity of dual lock-and-key-controlled siRNA delivery. The
cell-subtype recognition and siRNA-ONV delivery were further
veriﬁed with three different cells, HeLa, Ramos and CEM cells
(Fig. 3). The bright ﬂuorescence from Cy3-siRNA-ONV was only
observed within CEM cells. Only little ﬂuorescence was observed
from Ramos and HeLa cells, demonstrating the speciﬁc
recognition and precise delivery of siRNA to target cells. To
examine the possible off-target delivery through the diffusion of
activated siRNA-ONV or direct physical contact of neighbouring
cells, the mixture of HeLa and Ramos cells or HeLa and CEM
cells was treated with Cy3-siRNA-ONV, respectively. Both HeLa
and Ramos cells showed little ﬂuorescence, while CEM cells
showed bright ﬂuorescence, indicating that proximity-based
siRNA delivery was dominant. The ﬂuorescence intensity of CEM
cells was 4.6-fold that of HeLa cells (Supplementary Fig. 5),
suggesting thatB82.1% of activated siRNA-ONV in the mixture
was internalized in CEM cells. To further demonstrate the
advantages of dual parameters controlled cell-subtype-speciﬁc
recognition and delivery, we also designed a single-parameter-
controlled delivery vehicle as a negative control Cy3-siRNA-ONV
(S-Cy3-siRNA-ONV). The ONV nanotube was modiﬁed with a
single-strand DNA oligonucleotide instead of auto-cleavable
hairpin structure oligonucleotide. The single-strand DNA
oligonucleotide had the same sequence as the rest part of the
auto-cleavable hairpin structure oligonucleotide after cleavage
and could recognize lock aptamer sgc8c. However, the
single-membrane receptor-controlled delivery system could not
provide sufﬁcient cell-subtype selectivity, ﬂuorescence from
S-Cy3-siRNA-ONV was observed from both CEM and HeLa cells
(Supplementary Fig. 6).
Internalization process of siRNA-ONV. To conﬁrm the
integrity of siRNA-ONV nanostructures when they crossed
through cell membrane, Cy3 and Cy5 were labelled on different
siRNA-TRUs and the assembled siRNA-ONV was incubated with
CEM cells for 2 h. The co-localization experiment showed that the
ﬂuorescence from Cy3 and Cy5 appeared nearly in the same place
(Fig. 4a). To study the internalization process of siRNA-ONV,
co-staining experiment was further performed by staining
lysosomes with LysoTracker Green and cell nucleus with
40,6-diamidino-2-phenylindole (DAPI). Cy3-siRNA-ONV was
localized in lysosomes on the same sites after incubation with
CEM cells for 2 h by the overlap of red (Cy3-siRNA-ONV) and
green (lysosome) ﬂuorescence (Fig. 4b), indicating successful
cellular internalization of the Cy3-siRNA-ONV through endo-
cytosis. After incubation with Cy3-siRNA-ONV for 6 h, weaker
ﬂuorescence of LysoTracker Green was observed (Fig. 4b),
suggesting the spreading of LysoTracker Green from acidic
lysosome to neutral cytoplasm32,33, since the staining of lysosome
by the tracker was dependent on the acidicity34. These
phenomena clearly demonstrated the efﬁcient translocation or
escape of Cy3-siRNA-ONV from lysosomes into the cytoplasm
due to the rupture of the lysosomal membrane33,35. During the
endocytosis process, the rigid structure of self-assembled ONV
nanotube could carry siRNA crossing through cell membrane and
protect them from degradation29. The successful endosomal
escape was also attributed to the rigid linear structure with high
aspect ratio of ONV nanotube36–38. To demonstrate the rigid
structure of ONV prompts endosomal escape process, a control
Cy3-siRNA-ONV without rigid structure (Cy3-siRNA-ONV-NR)
was synthesized by mixing siRNA-TRU with DNA backbone at a
lower ratio of 0.5:1. No ﬂuorescence colour separation was
observed after incubating Cy3-siRNA-ONV-NR with CEM cells
for 6 h, indicating the failure of endosomal escape process in the
absence of rigid structure (Fig. 4c). To further validate the
endosomal escape, calcein was used to monitor the stability of
lysosomes after Cy3-siRNA-ONV uptake32. After CEM cells were
treated with the mixture of calcein and Cy3-siRNA-ONV for 6 h,
they showed the spreading of calcein to the cytoplasm with strong
calcein ﬂuorescence and yellow ﬂuorescence resulted from the
overlap of red Cy3 and green calcein ﬂuorescence (Supplementary
Fig. 7b), while the cells treated with calcein alone or the mixture
of calcein and Cy3-siRNA-ONV-NR only showed the weaker
ﬂuorescence inside the endosomes (Supplementary Fig. 7a,c).
These results demonstrated the success of endosomal escape of
Cy3-siRNA-ONV39,40. To evaluate the particular internalization
pathway of the Cy3-siRNA-ONV into the cells, a series of
inhibitors were employed to selectively block different
internalization processes (Supplementary Fig. 8). Treatment of
the cells with NaN3 and sucrose led to a 50–60% reduction in
Cy3-siRNA-ONV uptake, suggesting Cy3-siRNA-ONV
experienced the clathrin-dependent endocytosis pathway upon
entering the cells.
Characterization of siRNA release. In RNAi, the siRNA strands
are generally loaded into the RNA-induced silencing complex,
and the antisense strand is separated from sense strand to silence
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Figure 3 | Speciﬁcity of ‘dual lock-and-key’-controlled siRNA delivery.
Confocal microscopy images of HeLa, Ramos, CEM cells, the mixture of
HeLa and Ramos cells, and the mixture of HeLa and CEM cells after
incubation with 100nM Cy3-siRNA-ONV for 2 h. All the cells were
pretreated with sgc8c and sgc4f aptamers. Scale bars, 50mm.
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corresponding gene and suppress protein expression41. Here
siRNA duplexes were released from ONV nanotube in the
cytoplasm, which was demonstrated from the PAGE analysis of
the mixture of siRNA-ONV and CEM cell lysate (Supplementary
Fig. 9a)42,43, and then incorporated into the RNA-induced
silencing complex before it participates in RNAi. This result
was also conﬁrmed by ﬂuorescence spectra assay (Supplementary
Fig. 9b,c). A strong ﬂuorescent of Cy3 was obtained after over
24-h incubation of SQ-siRNA-ONV with CEM cell lysates,
indicating the successful SQ-siRNA-ONV disassembly and
siRNA release in cell microenvironment. To further conﬁrm the
successful siRNA release in the cytoplasm, SQ-siRNA-ONV was
also incubated with CEM cells over 24 h (Supplementary Fig. 9d).
These cells showed negligible ﬂuorescence after 6-h incubation,
suggesting the integrity of SQ-siRNA-ONV during the endosomal
escape process. However, after 24-h incubation, the ﬂuorescence
of Cy3 was clearly observed in CEM cells, which demonstrated
the successful disassembly of SQ-siRNA-ONV and release of
siRNA in cells.
Cytotoxicity assay. The cytotoxicity was evaluated with a
standard 3-(4,5-Dimethylthiazol-2-yl)-2-diphenyltetrazolium
bromide (MTT) assay at a series of ONV concentrations, and
the results were compared with standard transfection agents,
Lipofectamine 2000 (Lipo2000) and Trans IT-TKO (TKO)44,45.
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Figure 4 | Characterization of endosomal escape. (a) Confocal ﬂuorescence microscopic images of CEM cells incubated with Cy3/Cy5-siRNA-ONV.
Cy3 and Cy5 were labelled on different siRNA-TRU and self-assembled together to form Cy3/Cy5-siRNA-ONV. The cell nucleus was stained with DAPI.
The merge image shows co-localization of both ﬂuorophores in cytoplasm of CEM cells. (b–c) Co-staining of CEM cells with LysoTracker Green and
DAPI after incubated with (b) Cy3-siRNA-ONV and (c) Cy3-siRNA-ONV-NR for 2 and 6 h. Scale bars, 10mm.
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Even at very high concentration of 0.5 mM ONV, CEM cells still
kept 96.5% viability (Supplementary Fig. 10). In comparison, the
cells treated with Lipo2000 and TKO only exhibited 87.1% and
89.6% viability, respectively. The non-cytotoxicity and good
biocompatibility of ONV guaranteed its potential application in
clinical intervention.
Gene silencing assay. Vascular endothelial growth factor (VEGF)
has been identiﬁed as a mitogen and important regulator of
angiogenesis, and appeared to be involved in the vascular phase
of many different neoplastic diseases. It is a promising approach
for human acute lymphoblastic leukaemia treatment through
blocking VEGF expression to inhibit tumour vascularization and
growth46,47. To evaluate the therapeutic effect of ‘dual lock-and-
key’-controlled siRNA delivery, VEGF was selected as a model
therapeutic target and the siRNA-ONV were delivered into target
CEM cells against VEGF. After the CEM cells bound with sgc4f
and sgc8c aptamers and incubated with 100 nM siRNA-ONV for
48 h, the VEGF messenger RNA (mRNA) and VEGF protein
expression levels were determined by real-time PCR assay and
enzyme-linked immunosorbent assay (ELISA), and the treatment
efﬁciency was also compared with siRNA-loaded lipo2000 and
TKO (siRNA-lipo2000 and siRNA-TKO). A negative control
siRNA-ONV (NCsiRNA-ONV) and a second active VEGF
siRNA-loaded ONV (2nd-siRNA-ONV) were also synthesized
using negative control siRNA and another active siRNA with a
different effective sequence to perform the comparison. As
observed in Fig. 5, CEM cells treated with just ONV complexes,
NCsiRNA-ONV or only ds-siRNA showed little inhibition of
VEGF mRNA expression or VEGF protein synthesis. Both the
mRNA and protein expression percentage were little decreased
compared with CEM cells without any treatment (control). The
‘dual lock-and-key’-controlled delivery approach (siRNA-ONV)
demonstrated effective VEGF gene silencing in target cells by
inhibiting the VEGF mRNA expression down to 47.1%
and VEGF protein production down to 49.1%48–50, which
was comparable with Lipo2000 mediation transfection, TKO
mediation transfection and 2nd-siRNA-ONV.
Cell apoptosis assay. MTT assay was also used to verify the
inhibition effect of siRNA-ONV to CEM cell proliferation. After
the CEM cells were incubated with siRNA-ONV, 2nd-siRNA-
ONV, siRNA-Lipo2000 or siRNA-TKO for 2 h, their viabilities
were compared with those of untreated cells, the cells only treated
with ds-siRNA, ONV complex and NCsiRNA-ONV. The
ds-siRNA-, ONV complex- or NCsiRNA-ONV-treated cells did
not show inhibition effect, and their cell proliferation percentages
still remained at B100% (Supplementary Fig. 11a). In contrast,
siRNA-ONV demonstrated signiﬁcant inhibition effect on cell
proliferation, and the cell proliferation percentage decreased
down to 55.7%, at the same level as 2nd-siRNA-ONV, siRNA-
Lipo2000 or siRNA-TKO. Moreover, the inhibition percentage of
cell proliferation for siRNA-ONV also showed dose-dependent,
and the cell proliferation percentage decreased with the increasing
siRNA loading (Supplementary Fig. 11b). To further evaluate the
therapeutic effect of siRNA-ONV, the cell apoptosis was studied
by ﬂow cytometric assay using the Annexin V-ﬂuorescein
isothiocyanate (FITC)/propidium iodide (PI) apoptotic kit
(Supplementary Fig. 11c). The apoptosis rate for cells treated with
siRNA-ONV was 49.3%, comparable with 2nd-siRNA-ONV,
siRNA-lipo2000 and siRNA-TKO, and B16 times improvement
than ds-siRNA. These results demonstrated the feasibility of ‘dual
lock-and-key’-controlled siRNA delivery as a promising approach
for efﬁcient anticancer therapeutics.
Therapeutic efﬁcacy under serum condition. To evaluate the
therapeutic efﬁcacy of siRNA-ONV and 2nd-siRNA-ONV under
serum condition, the gene silencing and cell apoptosis assays were
performed under both serum and serum-free conditions. The
mRNA expression, protein secretion level and cell proliferation
under serum condition showed consistent results with those in
reaction buffer (Supplementary Fig. 12), suggesting that the
serum did not affect the ‘dual lock-and-key’-controlled siRNA
delivery process.
In vivo therapeutic applicability. To demonstrate the in vivo
inhibition of VEGF expression and the antitumour efﬁcacy of this
strategy, the mixture of sgc4f and sgc8c aptamers was ﬁrst
intratumorally injected into mice bearing CEM xenograft tumour
for 30min, and siRNA-ONV, NCsiRNA-ONV, reaction buffer,
siRNA-Lipo2000 and siRNA-TKO were then intratumorally
injected into these mice, respectively. SiRNA-Lipo2000-, siRNA-
TKO- and siRNA-ONV-injected mice presented pronounced
inhibition efﬁcacy towards tumour growth compared with the
control and NCsiRNA-ONV groups (Fig. 6a). Although the cell
experiments for performing siRNA-ONV-, siRNA-Lipo2000- and
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Figure 5 | Silencing of target VEGF gene in CEM cells. (a) Real-time PCR characterization of mRNA expression for CEM cells incubated with ONV,
NCsiRNA-ONV, ds-siRNA, siRNA-Lipo2000, siRNA-TKO, siRNA-ONV and 2nd-siRNA-ONV. (b) ELISA characterization of protein secretion levels for
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siRNA-TKO-induced VEGF gene silencing did not show
signiﬁcant difference (Fig. 5), in vivo experiments demonstrated
slightly higher efﬁcacy (Po0.05) of siRNA-ONV than siRNA-
Lipo2000 and siRNA-TKO for inhibiting tumour growth
(Fig. 6a), suggesting that the high selectivity of ‘dual lock-and-
key’ strategy enhanced in vivo antitumour activity. Consistently,
the immunoﬂuorescence staining of tumour tissue section
showed less VEGF protein expression in siRNA-ONV-treated
mice than siRNA-Lipo2000-, siRNA-TKO-, NCsiRNA-ONV-
and reaction buffer-treated mice (Fig. 6b), demonstrating the
downregulated expression level of cytoplasmic VEGF.
Discussion
In this study, we design a ‘dual lock-and-key’ system for gene
interference, which achieves cell-subtype-speciﬁc siRNA delivery
with high gene silencing efﬁciency. The siRNA-ONV is prepared
by assembling siRNA-TRU repeating units with a DNA backbone
produced by RCA, which is used as both the ‘smart key’ and the
delivery carrier. The rigid structure of ONV with the high aspect
ratio protects siRNA from nuclease degradation (Fig. 2c;
Supplementary Fig. 1) when it crosses through the cell
membrane, and prompts endosomal escape in the cytoplasm
(Fig. 4b). The average length of siRNA-ONV is 0.60±0.15 mm
with high loading amount of siRNA up to 84±20mm (Fig. 2c),
offering high delivery efﬁciency. Two aptamers sgc8c and sgc4f
that bind to different cell surface receptors act as ‘dual locks’
sequentially to react with ‘smart key’ siRNA-ONV, thus achieving
high speciﬁc recognition and siRNA delivery. Both the aptamer
‘locks’ and the self-assembled oligonucleotide nanotube ‘smart
key’ can be designed and conveniently synthesized by mature
DNA self-assembly technique with high yield and low cost29,30.
The speciﬁcity of ‘dual lock-and-key’-controlled siRNA
delivery is veriﬁed by using HeLa and Ramos cells as controls.
Both CEM and Ramos cells belong to lymphoma cell lines and
display the same surface marker sgc4f, and CEM and HeLa cells
display the same surface marker sgc8c (Supplementary Fig. 3).
These three kinds of cells are indistinguishable for single-
receptor-mediated recognition and delivery therapies, therefore
multiple cell surface receptors are needed to participate in the
delivery process to increase speciﬁcity and eliminate off-target
toxicities. Through sequential reaction with aptamers sgc8c and
sgc4f that, respectively, bind to two different cell membrane
receptors, the siRNA is delivered into target CEM cell via the
‘dual lock-and-key’-controlled system (Supplementary Fig. 4).
This strategy shows negligible off-target toxicity (Fig. 3), which
overcomes potential risk in the conventional single-receptor-
targeted delivery system (Supplementary Fig. 6).
The nanomaterials with rigid structure and high aspect ratio
such as cerium oxide nanowires and polymer nanoneedles
generally exhibit better capability of cellular internalization and
endosomal escape, as well as longer circulation times than
spherical structure36,38. Self-assembled DNA nanoribbon is rigid
with high aspect ratio and has been conﬁrmed to assist
endosomal escape in gene delivery37. The siRNA-ONV
nanotube has the rigid and tube-like features with high aspect
ratio (Fig. 2c) and demonstrates efﬁcient endosomal escape by the
co-localization experiment with dyes LysoTracker Green and
DAPI (Fig. 4b). In comparison, a control siRNA-ONV without
rigid structure (siRNA-ONV-NR) shows the failure of endosomal
escape (Fig. 4c), supporting the proposed mechanism of
endosomal escape. Compared with other endosomal escape
technique based on positively charged polymer51, self-assembled
DNA nanostructure simpliﬁes synthesis steps and has better
biocompatibility, therefore can be used as a universal delivery
vehicle for siRNA, drug and protein for cancer therapy.
In conclusion, we present a strategy of the ‘dual lock-and-key’
system with structure switchable smart key for cell-subtype-
speciﬁc siRNA delivery and gene silencing. SiRNA-ONV is
activated on site at CEM cell membrane by reacting with aptamer
sgc4f, and subsequently reacts with sgc8c to achieve precise VEGF
siRNA delivery. ONV is synthesized by DNA self-assembly
technique with a convenient procedure, providing good biocom-
patibility, high loading efﬁciency with no adverse side effects. The
structure of ONV can protect siRNA from degradation during
endocytic process and guarantee efﬁcient release from lysosomes.
The self-assembled nanostructure vehicle could be conveniently
functionalized and extended as a robust strategy for speciﬁc
precise delivery of other functional nucleic acids or DNA-binding
proteins. This ‘dual lock-and-key’ strategy provides impressive
improvement over the single-receptor delivery system by
increasing delivery speciﬁcity and inhibiting off-target cytotoxi-
city, therefore is of great importance for siRNA-targeted delivery
and tumour therapy.
Methods
Reagents. MTT and calcein were purchased from Sigma-Aldrich (USA). Phi29
DNA polymerase, T4 DNA ligase, exonuclease I, exonuclease III and dNTPs were
purchased from New England Biolabs Ltd. Annexin V-FITC apoptosis detection
kit was purchased from BD Biosciences (USA). Anti-VEGF primary antibody
(19003-1-AP) was purchased from Proteintech Group (USA) and 50 times diluted
during experiments. FITC-conjugated secondary antibody (111-095-003) was
purchased from Jackson ImmunoResearch (USA) and 100 times diluted during
experiments. LysoTracker Green and DAPI were purchased from Invitrogen
(Carlsbad, CA, USA). SYBR Green I was obtained from Generay Biotech Co., Ltd
(China). PBS (pH 7.4) contained 136.7mM NaCl, 2.7mM KCl, 8.72mM Na2HPO4
and 1.41mM KH2PO4. The reaction buffer was prepared using the PBS containing
0.5mM MgCl2 and 50 mM ZnCl2, which helped the efﬁcient binding between
aptamers and receptors, as well as providing MNAzyme with Zn2þ for auto-
catalytical cleavage of hairpin structure from the ONV. TAMg buffer (1 ) was
composed of 45mM Tris and 7.6mM MgCl2, with pH adjusted to 8.0 using glacial
acetic acid. All other reagents were of analytical grade. All aqueous solutions were
prepared using ultrapure water (Z18MO, Milli-Q, Millipore). siRNAs were
obtained from GenePharma Co. Ltd (Shanghai, China). The siRNA sequences were
as follows: VEGF siRNA, Cy3-sense 50-Cy3-GGAGUACCCUGAUGAGAUCd
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Figure 6 | In vivo demonstration of therapeutic applicability via target VEGF gene silencing. (a) Change of CEM tumour volume after treatment with
reaction buffer, NCsiRNA-ONV, siRNA-Lipo2000, siRNA-TKO or siRNA-ONV through intratumoral delivery. The data error bars indicate means±s.d.
(n¼ 5). *Po0.05, **Po0.01 (two-tailed Student’s t-test). (b) Expression of VEGF in CEM tumour tissue sections evaluated by immunoﬂuorescence
staining.
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TdT-30, Cy5-sense 50-Cy5-GGAGUACCCUGAUGAGAUCdTdT-30 , antisense
50-GAUCUCAUCAGGGUACUCCdTdTCAAAUGGACCAAGGCCAG-30 , 21
base antisense 50-GAUCUCAUCAGGGUACUCCdTdT-30 ; second active VEGF
siRNA, sense 50-ACCUCACCAAGGCCAGCACdTdT-30 , antisense 50-GUGCUG
GCCUUGGUGAGGUdTdTCAAAUGGACCAAGGCCAG-30 ; negative control
siRNA, sense 50-UUCUCCGAACGUGUCACGUdTdT-30 and antisense 50-ACG
UGACACGUUCGGAGAAdTdTCAAAUGGACCAAGGCCA G-30. All of the
DNA were synthesized and puriﬁed by Sangon Biotech Co., Ltd (Shanghai, China).
Their sequences were listed in Supplementary Table 1.
Apparatus. Absorption spectra were recorded on an UV-3600 UV–vis-NIR
spectrophotometer (Shimadzu Company, Japan). The gel electrophoresis was
performed on the DYCP-31BN Electrophoresis Analyser (Liuyi Instrument
Company, China) and imaged on a Bio-Rad ChemDoc XRS (Bio-Rad, USA).
Fluorescence spectra were measured on an F-7000 spectroﬂuorophotometer
(HITACHI, Japan). Confocal ﬂuorescence imaging of cells was performed on a
TCS SP5 confocal laser scanning microscope (Leica, Germany). Flow cytometric
analysis was performed on a Coulter FC-500 ﬂow cytometer (Beckman-Coulter).
MTT and ELISA assays were carried out on Hitachi/Roche System Cobas 6000
(680, Bio-Rad, USA). Real-time PCR and melting curve measurement were
performed on the CFX96 touch real-time PCR detection system (Bio-Rad, USA).
AFM imaging was performed under ambient conditions with an Agilent 5500
AFM/SPM system (USA).
Preparation of circular DNA template. A volume of 4.2 ml of 100mM
phosphorylated linear DNA and 4.2 ml of 100 mM ligation DNA was mixed
and annealed at 95 C for 4min. After the mixture was slowly cooled to room
temperature over 2 h, 1 ml of T4 DNA ligase (400U ml 1), 2 ml of 10 T4 DNA
buffer and 8.6 ml of ultrapure water were added and the solution was incubated at
25 C for 16 h. The T4 DNA ligase was inactivated by heating at 65 C for 10min.
A volume of 4 ml of exonuclease I (20U ml 1) and 4 ml of exonuclease III
(100U ml 1) was added in the following, the mixture was then incubated at 37 C
for 8 h to degrade ligation DNA. After heating at 80 C for 15min to denature the
exonuclease I and exonuclease III, the circular DNA template was obtained and
stored at 4 C before use.
Preparation of DNA backbone. The DNA backbone was prepared by RCA52.
A volume of 10ml of 3 mM circular DNA template and 0.5 ml of 100 mM DNA
primer was mixed and annealed at 95 C for 4min. Then, the mixture was cooled
to room temperature over 2 h and incubated with phi29 DNA polymerase
(0.2U ml 1), bovine serum albumin (0.4 mg ml 1) and dNTPs (0.1mM) at 37 C
for 5 h in 150 ml of 1 phi29 reaction buffer. After reaction, the mixture was
incubated at 65 C for 10min to denature the phi29 DNA polymerase, and then
puriﬁed by ultraﬁltration (100,000 molecular weight cutoff membrane, Millipore)
for three times to obtain the DNA backbone. DNA backbone has repeating strand
segments with sequences complementary to TRU. The concentration of the repeat
unit in DNA backbone was obtained by measuring ultraviolet absorbance at
260 nm and used as the concentration of DNA backbone29.
Preparation of siRNA-ONV. The ONV was prepared based on a modiﬁed
assembly strategy28. In brief, TRU was synthesized by the equimolar mixing of
strands C1, C2, V1, R1 and R2 with a ﬁnal concentration of 5 mM in 1 TAMg
buffer. This mixture was annealed at 95 C for 4min and cooled to room
temperature over 2 h. The ONV was generated by equimolar mixing the TRU with
DNA backbone for 2 h at room temperature. To generate siRNA-modiﬁed ONV
(siRNA-ONV), the siRNA-TRU was prepared by mixing of strands V1, C1, C2, R1,
R2, siRNA and antisense siRNA at a ratio of 1:1:1:1:1:2:2 and assembled with
equimolar DNA backbone. The control Cy3-siRNA-ONV without rigid structure
(Cy3-siRNA-ONV-NR) was prepared by mixing of siRNA-TRU with DNA
backbone at a ratio of 0.5:1.
PAGE analysis. Native polyacrylamide gel (8%) was prepared using 1 TBE
buffer. The loading sample was prepared by mixing 7 ml DNA sample, 1.5 ml 6
loading buffer and 1.5 ml UltraPowerTM dye, and placed still for 3min before
injected into polyacrylamide hydrogel. The gel electrophoresis was run at 90V for
60min in 1 TBE buffer and scanned using a Molecular Imager Gel Doc XR.
AFM imaging. A volume of 6 ml sample was deposited on freshly cleaved mica
surface and incubated for 2min. After wicked away with ﬁlter paper, 20 ml
ultrapure water was added to wash the mica for two times. The mica was then dried
with a nitrogen ﬂow and scanned in tapping mode.
Serum stability of siRNA-ONV. To verify the serum stability of siRNA-ONV,
Cy3-tagged siRNA and BHQ2-tagged R1 and R2 oligonucleotides were used as
components to assemble SQ-siRNA-ONV. SQ-ds-siRNA was also synthesized by
assembling Cy3-tagged siRNA and BHQ2-tagged R1 and R2, and used as control.
Fluorescence from Cy3 was quenched in the beginning due to the close distance
between Cy3 and BHQ2. Then, 50 nM of SQ-siRNA-ONV (100 nM ﬂuorophore
concentration) and 100 nM of SQ-ds-siRNA were separately diluted with FBS to
yield a ﬁnal concentration of 50 nM ﬂuorophore in 10% FBS 1 TAMg. The
mixture was incubated at 37 C for 12 h, ﬂuorescence signal recovery was observed
with the disassembly of SQ-siRNA-ONV nanotube and release of siRNA. The
ﬂuorescence signal recovery was measured every hour with 510 nm excitation and
560 nm emission.
Thermal stability of siRNA-ONV. The sample for thermal stability assay was
prepared by mixing the 19 ml of 1 mM siRNA-ONV sample solution with 1 ml of
20 SYBR Green I in 0.2ml PCR tubes (white). Fluorescence data for melting
curves were obtained with the real-time PCR detection system (Bio-Rad) during
the temperature increase from 30 to 90 C at 0.2 C s 1 and held for 15 s in every
temperature point53.
Cell culture. HeLa cells (KeyGEN Biotech, Nanjing, China) were cultured in
DMEM supplemented with 10% FBS, 100 mgml 1 streptomycin and 100Uml 1
penicillin–streptomycin at 37 C in a humidiﬁed incubator containing 5% CO2 and
95% air. CCRF-CEM (CCL-119, T-cell line, human acute lymphoblastic leukaemia
(ALL)) from KeyGEN Biotech and Ramos (CRL-1596, B-cell line, human Burkitt’s
lymphoma) from Cobioer Biosciences (Nanjing, China) were cultured in RPMI
1640 medium containing 10% FBS and 100Uml 1 penicillin–streptomycin at
37 C in a humidiﬁed incubator containing 5% CO2 and 95% air. Short tandem
repeats (STR) proﬁling and mycoplasma testing were conducted for each cell line
before use. Cell numbers were determined with a Petroff-Hausser cell counter
(USA).
Characterization of aptamers speciﬁcity. Sgc8c and sgc4f aptamers were labelled
with FAM to characterize the aptamer-binding speciﬁcity to different cells.
FAM-labelled aptamers were incubated with CEM, Ramos and HeLa cells at 37 C
for 30min, and then subjected to ﬂow cytometric assay over FL1 channel.
Confocal ﬂuorescence imaging and ﬂow cytometric assay. A concentration
of 50 nM of sgc4f and sgc8c aptamer probes was incubated with 1 104
corresponding cells in reaction buffer for 30min at room temperature. After the
cells were centrifuged at 156g for 5min and washed twice with the reaction buffer,
100 nM of Cy3-siRNA-ONV was added and incubated with the cells for 2 h
at 37 C. After washing twice to remove nonbinding Cy3-siRNA-ONV, the
ﬂuorescence of cells was visualized from 550 to 610 nm on the confocal laser
scanning microscope (CLSM; TCS SP5, Leica, Germany) with the excitation
wavelength of 514 nm for Cy3. All images were digitized and analysed with Leica
Application Suite Advanced Fluorescence software package. To conﬁrm inter-
nalization of Cy3-siRNA-ONV in the CEM cells, the vertical section scanning
along the z axis was performed. While moving the focal plane in incremental steps
from the bottom to the top of the cell within a 12 mm focal plane distance at the z
position, 20 confocal ﬂuorescence microscopy images were taken and recorded.
The ﬂow cytometric assay was performed in the PBS and used FL2 channel.
Cell co-localization assay. Cy3-labelled siRNA (Cy3-siRNA) and Cy5-labelled
siRNA (Cy5-siRNA) were self-assembled with other DNA strand component
to form siRNA-TRU, respectively, and the resulting Cy3-siRNA-TRU and
Cy5-siRNA-TRU were mixed with equimolar DNA backbone to generate the
Cy3/Cy5-siRNA-ONV. After loading with Cy3/Cy5-siRNA-ONV, 5.0 mgml 1
DAPI was added in CEM cells and incubated 15min for imaging. DAPI was
excited with a violet 405-nm laser diode and the emission was collected from 450 to
500 nm. Cy3 was excited at 543 nm with a HeNe 543 laser and the emissions were
collected from 560 to 620 nm. Cy5 was excited at 633 nm with a HeNe 633 laser
and the emissions were collected from 650 to 700 nm.
Endosomal escape of siRNA-ONV. To visualize the co-localization of inter-
nalized siRNA-ONV with endosomal compartments, the aptamer-bound CEM
cells were incubated with Cy3-siRNA-ONV and Cy3-siRNA-ONV without rigid
structure (Cy3-siRNA-ONV-NR) at siRNA concentration of 200 nM for 2 or 6 h
at 37 C. Then, the cells were washed with PBS and stained with 100 nM of
LysoTracker Green and 5 mgml 1 of DAPI for 15min for imaging. LysoTracker
Green was excited at 488 nm with an argon ion laser and the emission was collected
from 505 to 535 nm.
The endosomal escape was further demonstrated with calcein release assay by
incubating the aptamer-bound CEM cells with the mixture of 25 mM calcein and
Cy3-siRNA-ONV or Cy3-siRNA-ONV-NR for 6 h at 37 C and then washing these
cells with PBS. Calcein was excited at 488 nm with an argon ion laser and the
emission was collected from 500 to 530 nm.
Endocytosis pathways of siRNA-ONV. The uptake inhibitors of 450mM sucrose,
200 mgml 1 genistein, 50mM methyl-b-cyclodextrin (Me-b-CD), 50 nM
wortmannin and 10mM NaN3 were preincubated with CEM cells for 30min to
inhibit clathrin, caveolae, lipid raft, macropinocytosis and energy-dependent
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endocytosis, respectively37,54. Then, the cells were loaded with Cy3-siRNA-ONV
and the inhibitors were maintained throughout the experiments. After that, ﬂow
cytometric analyses were performed to determine the uptake amount of
Cy3-siRNA-ONV.
Release of siRNA. siRNA release process was ﬁrst conﬁrmed in cell lysates. A total
of 5 107 cells were washed twice with cold PBS (pH 7.4) and resuspended in
200ml of hypotonic lysis buffer containing 20mM HEPES-KOH, pH 7.4, 10mM
KOAc, 1.5mM Mg(OAc)2, 5mM dithiothreitol, 0.1% Tween-20 and 1
EDTA-free protease inhibitor cocktail. The mixture was incubated for 10min on
ice and centrifuged at 35,200g and 4 C for 20min. The supernatant was collected
and diluted to 200ml as cell lysates for detection. A concentration of 50 nM
SQ-siRNA-ONV with 100 nM ﬂuorophore concentration was added in cell lysates
or 1 TAMg buffer. The mixture was incubated at 37 C for 24 h to measure
the ﬂuorescence signal with 510-nm excitation and 560-nm emission. For PAGE
assay, 4 ml cell lysate was incubated with 4 ml siRNA-ONV at 37 C for 1 h and
subsequently resolved on a 8% native polyacrylamide gel as described above.
To characterize the intracellular release of siRNA from siRNA-ONV, the
SQ-siRNA-ONV was incubated with CEM cells for 24 h, and the ﬂuorescence
recovery from released Cy3-siRNA after SQ-siRNA-ONV disassembly was imaged
with CLSM.
MTT assay. MTT assay was carried out to investigate the cytotoxicity of ONV.
CEM cells (5 105 per well) were seeded into two 96-well plates in 200 ml reaction
buffer containing 50 nM of sgc4f and sgc8c aptamers for 30min. Then, the cells
were washed with PBS and incubated with serial concentrations of the ONV for
2 h. The results were compared with commercial transfection agent, 0.4 ml of
Lipo2000 and TKO. Cells incubated with PBS served as control. The cells were
washed twice with PBS buffer in the following and 50 ml of 5mgml 1 MTT
solution was added and incubated for 4 h. After removing medium, 150 ml of
dimethylsulphoxide was added to dissolve the formazan crystals precipitates.
After shaking the cell plate for 15min, the optical density at a wavelength of
490 nm was measured with a Bio-Rad microplate reader. The relative cell viability
(%) was calculated by (Atest/Acontrol) 100. Negative control siRNA-ONV
(NCsiRNA-ONV) was synthesized by using negative control siRNA instead of
VEGF siRNA for cell proliferation assay. NCsiRNA-ONV, ds-siRNA,
siRNA-Lipo2000, siRNA-TKO and siRNA-ONV at siRNA concentration of
200 nM or equivalent ONV concentration of 100 nM were incubated with CEM
cells for 2 h. After siRNA was transfected into CEM cells, fresh culture medium
containing 10% FBS was added and incubated with cells for 48 h. Then, the cell
proliferation was evaluated with the MTT assay.
Gene silencing assay. CEM cells were seeded into a 24-well plate at 5 105 cells
per well and incubated with 50 nM of sgc8c and sgc4f in 200 ml reaction buffer for
30min. After the cells were washed with PBS, 100 nM of siRNA-ONV was added
and incubated for 2 h at 37 C. Meanwhile, ONV, NCsiRNA-ONV, 2nd-siRNA-
ONV, ds-siRNA, siRNA-Lipo2000 and siRNA-TKO at siRNA concentration of
200 nM or equivalent ONV concentration of 100 nM were incubated with CEM
cells for 2 h as controls. After centrifugation to precipitate cells, the supernatant
medium was replaced by a fresh culture medium containing 10% FBS and further
cultured for 48 h. The supernatant of culture medium was collected and analysed
by ELISA to quantify VEGF secreted from the cells. Total RNAs from the
transfected CEM cells were extracted using the Trizol reagent (Invitrogen), and
complementary DNA was generated using the PrimeScriptRT reagent kit (Takara).
The synthesized complementary DNA was then run on the CFX96 real-time PCR
detection system (Bio-Rad, USA) to calculate VEGF mRNA level of cellular.
Cell apoptosis experiments. A total of 5.0 105 CEM cells were seeded in a
24-well plate in 200 ml reaction buffer containing 50 nM sgc8c and 50 nM sgc4f for
30min at room temperature. The cells were washed with PBS in the following and
incubated with 100 nM of siRNA-ONV for 2 h. The cells were also incubated with
ONV, NCsiRNA-ONV, 2nd-siRNA-ONV, ds-siRNA, siRNA-Lipo2000 and
siRNA-TKO at siRNA concentration of 200 nM or equivalent ONV concentration
of 100 nM under the same condition as the controls. After centrifugation of cells,
the supernatant medium were replaced with fresh culture medium containing 10%
FBS and further incubated for 48 h. The resulting cells were collected and stained
with the mixture of 5.0 ml Annexin V-FITC and 5.0 ml propidium iodide for 15min,
and then imaged with ﬂow cytometry over FL1 (Annexin V-FITC) and FL3 (PI)
channels.
Therapeutic efﬁcacy assay under serum condition. To characterize the
therapeutic efﬁcacy of siRNA-ONV and 2nd-siRNA-ONV under serum condition,
the internalization of siRNA-ONV and 2nd-siRNA-ONV in CEM cells was
performed in fresh culture medium containing 10% FBS, 0.5mMMgCl2 and 50 mM
ZnCl2, and then the resulting cells were evaluated with gene silencing and cell
apoptosis assays.
In vivo antitumour efﬁcacy. Speciﬁc pathogen-free female BALB/c nude mice,
5–6 weeks of age, were purchased from Shanghai Laboratory Animal Center,
Chinese Academy of Sciences, and bred in an axenic environment. All animal
procedures were in accordance with Institutional Animal Use And Care
Regulations approved by the Model Animal Research Center of Nanjing University
(MARC), which allowed the maximal diameter (length) of every tumour should
not exceed 20mm or the volume of every tumour should beo2.0 cm3. To establish
a CEM tumour model, 1.0 106 CEM cells were subcutaneous injected into the
selected position of the nude mice. When the tumour volumes reached to 75mm3,
the tumour-bearing mice were randomly divided into ﬁve groups and
intratumorally injected with 50 ml reaction buffer containing 200 pmol sgc8c and
200 pmol sgc4f, and subsequently injected with 50 ml reaction buffer (control),
NCsiRNA-ONV, siRNA-ONV, siRNA-Lipo2000 or siRNA-TKO at a dose of
500 pmol siRNA per mouse after 30min. The injections were performed every
other day for ﬁve times. The tumour sizes were measured every 2 days by a digital
caliper for 12 days, and the tumour volumes were calculated as V¼ (LW2)/2,
where L and W were the length and width of the tumour, respectively. Four days
after the ﬁnal injection, tumours were collected, washed by saline thrice, ﬁxed in
the 10% neutral buffered formalin, processed routinely into parafﬁn, sectioned at
4 mm and incubated with anti-VEGF primary antibody at 37 C for 2 h. The tissue
sections were washed with saline thrice, stained with FITC-conjugated secondary
antibody and the nuclei were counterstained with DAPI. The stained tissue sections
were observed with CLSM.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within the article and its Supplementary Information ﬁles or
from the author on request.
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